Ketoconazole price December 2025 and outlook (see chart below)
- India:US$44.54/KG, -0.1% down
Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.
NEED A QUICK DOWNLOAD?
ACCESS TO OUR FULL DATABASE IS US$399/YEAR, WITH A 30-DAY $50 TRIAL
GET THAT DOWNLOAD IN 3 MINUTES!
BusinessAnalytiq provides a database of hundreds of market & price trend data, as well as online tools to set up benchmarks and leading indicators.
Ketoconazole price index
This post is a summary of the Ketoconazole price developments. The price developments of Ketoconazole are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Ketoconazole price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.
The outlook for Ketoconazole prices is generated from different inputs including:
- Very recent price developments of immediate cost drivers of Ketoconazole prices
- Recent price developments of underlying feedstocks which drive the price of Ketoconazole
- Market futures for both cost drives and feedstocks of Ketoconazole prices
- Adjustment of current supply/demand imbalances in the Ketoconazole market
- Longer term trends in likely demand conditions
What is Ketoconazole and what is it used for
Ketoconazole is an imidazole antifungal medicine used to treat fungal (yeast) infections of the skin and scalp (for example dandruff, seborrhoeic dermatitis, tinea/“ringworm” and tinea versicolor). It has also been used systemically in the past for serious fungal infections, but topical (cream/shampoo) preparations are the common current uses.
How is Ketoconazole
Ketoconazole works by inhibiting fungal cell membrane synthesis (it blocks ergosterol synthesis), which stops fungal growth. It is available mainly as topical formulations (shampoos and creams — commonly 1% OTC and 2% prescription strengths), and historically as oral tablets. Oral ketoconazole is associated with significant safety concerns (notably serious, sometimes fatal liver injury and hormonal/adrenal effects) and regulators have restricted or suspended its routine oral use; topical products remain widely used.
How large is the global market for Ketoconazole
Market estimates vary by source and by whether reports count only ketoconazole products or broader antifungal categories. Specialist market reports give figures in the low-hundreds of millions of USD for ketoconazole alone (for example a 2024 estimate of about USD 109.5 million with modest projected growth), while other industry reports place the ketoconazole market in the ~USD 1.2 billion range for recent years (different methodology and scope likely explain the gap). In short, small-to-mid hundreds of millions to around a billion+ USD is reported depending on the provider and the exact product scope — check the specific report definitions before using a figure for business planning.
Where is it produced
Ketoconazole API and finished products are manufactured by multiple generic/API producers worldwide, with notable manufacturing in India and China and finished-product production spread across generic pharmaceutical companies globally. Industry supplier directories and API lists show many Indian and Chinese manufacturers and exporters, and established generic firms (for example several large Indian generics groups) supply ketoconazole APIs and formulations. If you need suppliers or WHO/CEP/FDA-compliant manufacturers for sourcing, consult API supplier directories and regulatory listings to confirm certificates and batch release documentation.